Work

Phase I Clinical Trial of Oral COL-3, a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Year: 2001

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2001.19.2.584

Authors: Michelle A. Rudek, William D. Figg, Valerie Dyer, William Dahut, Maria L. Turner, Seth M. Steinberg, David J. Liewehr, David R. Kohler, James M. Pluda, Eddie Reed

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: Protease and Inhibitor Mechanisms

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1911901193

FWCI: 7.069

Cites: 39

Cited by: 153

Related to: 10